Cancer Pain Market Report

China Cancer Pain Industry Market Research Report 2023-2029

  • POSTDATE：Oct 07, 2023
  • PAGES：179
  • REPORT CODE：GMM1835543
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.

    This report elaborates on the current development of the Cancer Pain industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Grunenthal Group

    • BioDelivery Science

    • Sanofi

    • Johnson?Johnson

    • Teva pharmaceuticals

    • Orexo

    • ProStrakan Group

    • GW Pharmaceuticals

    • Eli-Lilly

    By Type:

    • Non-Steroidal Anti-Inflammatory Drugs

    • Opioids

    • Others

    By Application:

    • Paracetamol Treatment-Related Immunotherapy

    • Hormone

    • Chemotherapy

    • Radiotherapy

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Cancer Pain Market Overview 2018-2029

    • 1.1 China Cancer Pain Industry Development Overview

    • 1.2 China Cancer Pain Industry Development History

    • 1.3 China Cancer Pain Industry Market Size (2018-2029)

    • 1.4 China Cancer Pain Market Analysis by Type from Production Side

      • 1.4.1 China Cancer Pain Production Volume, Production Value and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2029)

      • 1.4.2 China Cancer Pain Production Volume, Production Value and Growth Rate of Opioids (2018-2029)

      • 1.4.3 China Cancer Pain Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Cancer Pain Market Analysis by Application from Consumption End

      • 1.5.1 China Cancer Pain Sales Volume, Sales Value and Growth Rate of Paracetamol Treatment-Related Immunotherapy (2018-2029)

      • 1.5.2 China Cancer Pain Sales Volume, Sales Value and Growth Rate of Hormone (2018-2029)

      • 1.5.3 China Cancer Pain Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)

      • 1.5.4 China Cancer Pain Sales Volume, Sales Value and Growth Rate of Radiotherapy (2018-2029)

    • 1.6 China Cancer Pain Market Analysis by Region

      • 1.6.1 North China Cancer Pain Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Cancer Pain Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Cancer Pain Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Cancer Pain Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Cancer Pain Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Cancer Pain Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Cancer Pain Market Size and Growth Rate from 2018-2029

    Chapter 2 China Cancer Pain Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Cancer Pain Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Cancer Pain Market Status and Competition Analysis in 2023

      • 2.2.3 China Cancer Pain Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Cancer Pain Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Cancer Pain Industry Development

    Chapter 3 Cancer PainIndustry Chain Analysis

    • 3.1 Cancer Pain Industry Chain

    • 3.2 Cancer Pain Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Cancer Pain Market

    • 3.3 Cancer Pain Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Cancer Pain Market

    Chapter 4 China Cancer Pain Market, by Type

    • 4.1 China Cancer Pain Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Cancer Pain Total Production Volume and Growth Rate from Production Side

    • 4.5 China Cancer Pain Production Volume and Growth Rate, by Type

      • 4.5.1 China Cancer Pain Production Volume and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs

      • 4.5.2 China Cancer Pain Production Volume and Growth Rate of Opioids

      • 4.5.3 China Cancer Pain Production Volume and Growth Rate of Others

    Chapter 5 China Cancer Pain Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Cancer Pain Total Market Size and Growth Rate from Consumption End

    • 5.5 China Cancer Pain Market Size and Growth Rate, by Application

      • 5.5.1 China Cancer Pain Market Size and Growth Rate of Paracetamol Treatment-Related Immunotherapy

      • 5.5.2 China Cancer Pain Market Size and Growth Rate of Hormone

      • 5.5.3 China Cancer Pain Market Size and Growth Rate of Chemotherapy

      • 5.5.4 China Cancer Pain Market Size and Growth Rate of Radiotherapy

    Chapter 6 China Cancer Pain Market, by Region

    • 6.1 China Cancer Pain Production Volume and Production Value, by Region

    • 6.2 China Cancer Pain Sales Volume and Sales Value, by Region

    Chapter 7 North China Cancer Pain Market Analysis

    • 7.1 North China Cancer Pain Market, by Type

    • 7.2 North China Cancer Pain Market, by Application

    Chapter 8 Central China Cancer Pain Market Analysis

    • 8.1 Central China Cancer Pain Market, by Type

    • 8.2 Central China Cancer Pain Market, by Application

    Chapter 9 South China Cancer Pain Market Analysis

    • 9.1 South China Cancer Pain Market, by Type

    • 9.2 South China Cancer Pain Market, by Application

    Chapter 10 East China Cancer Pain Market Analysis

    • 10.1 East China Cancer Pain Market, by Type

    • 10.2 East China Cancer Pain Market, by Application

    Chapter 11 Northeast China Cancer Pain Market Analysis

    • 11.1 Northeast China Cancer Pain Market, by Type

    • 11.2 Northeast China Cancer Pain Market, by Application

    Chapter 12 Southwest China Cancer Pain Market Analysis

    • 12.1 Southwest China Cancer Pain Market, by Type

    • 12.2 Southwest China Cancer Pain Market, by Application

    Chapter 13 Northwest China Cancer Pain Market Analysis

    • 13.1 Northwest China Cancer Pain Market, by Type

    • 13.2 Northwest China Cancer Pain Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Grunenthal Group

        • 14.1.1 Grunenthal Group Company Profile

        • 14.1.2 Grunenthal Group Cancer Pain Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 BioDelivery Science

        • 14.2.1 BioDelivery Science Company Profile

        • 14.2.2 BioDelivery Science Cancer Pain Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Sanofi

        • 14.3.1 Sanofi Company Profile

        • 14.3.2 Sanofi Cancer Pain Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Johnson?Johnson

        • 14.4.1 Johnson?Johnson Company Profile

        • 14.4.2 Johnson?Johnson Cancer Pain Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Teva pharmaceuticals

        • 14.5.1 Teva pharmaceuticals Company Profile

        • 14.5.2 Teva pharmaceuticals Cancer Pain Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Orexo

        • 14.6.1 Orexo Company Profile

        • 14.6.2 Orexo Cancer Pain Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 ProStrakan Group

        • 14.7.1 ProStrakan Group Company Profile

        • 14.7.2 ProStrakan Group Cancer Pain Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 GW Pharmaceuticals

        • 14.8.1 GW Pharmaceuticals Company Profile

        • 14.8.2 GW Pharmaceuticals Cancer Pain Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Eli-Lilly

        • 14.9.1 Eli-Lilly Company Profile

        • 14.9.2 Eli-Lilly Cancer Pain Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Cancer Pain Industry Research Conclusions

    • 15.2 Cancer Pain Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Cancer Pain Industry Market Size (2018-2029)

    • Figure China Cancer Pain Production Volume, Production Value and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2029)

    • Figure China Cancer Pain Production Volume, Production Value and Growth Rate of Opioids (2018-2029)

    • Figure China Cancer Pain Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Cancer Pain Sales Volume, Sales Value and Growth Rate of Paracetamol Treatment-Related Immunotherapy (2018-2029)

    • Figure China Cancer Pain Sales Volume, Sales Value and Growth Rate of Hormone (2018-2029)

    • Figure China Cancer Pain Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)

    • Figure China Cancer Pain Sales Volume, Sales Value and Growth Rate of Radiotherapy (2018-2029)

    • Figure North China Cancer Pain Market Size and Growth Rate from 2018-2029

    • Figure Central China Cancer Pain Market Size and Growth Rate from 2018-2029

    • Figure South China Cancer Pain Market Size and Growth Rate from 2018-2029

    • Figure East China Cancer Pain Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Cancer Pain Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Cancer Pain Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Cancer Pain Market Size and Growth Rate from 2018-2029

    • Figure Cancer Pain Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Cancer Pain Market Share by Type in 2018

    • Figure China Cancer Pain Market Share by Type in 2023

    • Figure China Cancer Pain Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Cancer Pain Production Volume and Growth Rate of Non-Steroidal Anti-Inflammatory Drugs (2018-2023)

    • Figure China Cancer Pain Production Volume and Growth Rate of Opioids (2018-2023)

    • Figure China Cancer Pain Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Cancer Pain Market Share by Application in 2018

    • Figure China Cancer Pain Market Share by Application in 2023

    • Figure China Cancer Pain Total Market Size and Growth Rate from Consumption End

    • Figure China Cancer Pain Market Size and Growth Rate of Paracetamol Treatment-Related Immunotherapy (2018-2023)

    • Figure China Cancer Pain Market Size and Growth Rate of Hormone (2018-2023)

    • Figure China Cancer Pain Market Size and Growth Rate of Chemotherapy (2018-2023)

    • Figure China Cancer Pain Market Size and Growth Rate of Radiotherapy (2018-2023)

    • Table China Cancer Pain Production Volume by Region (2018-2023)

    • Table China Cancer Pain Production Volume Share by Region (2018-2023)

    • Figure China Cancer Pain Production Volume Share by Region (2018-2023)

    • Table China Cancer Pain Production Value by Region (2018-2023)

    • Table China Cancer Pain Production Value Share by Region (2018-2023)

    • Figure China Cancer Pain Production Value Share by Region (2018-2023)

    • Table China Cancer Pain Sales Volume by Region (2018-2023)

    • Table China Cancer Pain Sales Volume Share by Region (2018-2023)

    • Figure China Cancer Pain Sales Volume Share by Region (2018-2023)

    • Table China Cancer Pain Sales Value by Region (2018-2023)

    • Table China Cancer Pain Sales Value Share by Region (2018-2023)

    • Figure China Cancer Pain Sales Value Share by Region (2018-2023)

    • Table North China Cancer Pain Production Volume by Type (2018-2023)

    • Table North China Cancer Pain Production Volume Share by Type (2018-2023)

    • Figure North China Cancer Pain Production Volume Share by Type (2018-2023)

    • Table North China Cancer Pain Sales Volume by Application (2018-2023)

    • Table North China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Figure North China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Table Central China Cancer Pain Production Volume by Type (2018-2023)

    • Table Central China Cancer Pain Production Volume Share by Type (2018-2023)

    • Figure Central China Cancer Pain Production Volume Share by Type (2018-2023)

    • Table Central China Cancer Pain Sales Volume by Application (2018-2023)

    • Table Central China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Figure Central China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Table South China Cancer Pain Production Volume by Type (2018-2023)

    • Table South China Cancer Pain Production Volume Share by Type (2018-2023)

    • Figure South China Cancer Pain Production Volume Share by Type (2018-2023)

    • Table South China Cancer Pain Sales Volume by Application (2018-2023)

    • Table South China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Figure South China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Table East China Cancer Pain Production Volume by Type (2018-2023)

    • Table East China Cancer Pain Production Volume Share by Type (2018-2023)

    • Figure East China Cancer Pain Production Volume Share by Type (2018-2023)

    • Table East China Cancer Pain Sales Volume by Application (2018-2023)

    • Table East China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Figure East China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Table Northeast China Cancer Pain Production Volume by Type (2018-2023)

    • Table Northeast China Cancer Pain Production Volume Share by Type (2018-2023)

    • Figure Northeast China Cancer Pain Production Volume Share by Type (2018-2023)

    • Table Northeast China Cancer Pain Sales Volume by Application (2018-2023)

    • Table Northeast China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Table Southwest China Cancer Pain Production Volume by Type (2018-2023)

    • Table Southwest China Cancer Pain Production Volume Share by Type (2018-2023)

    • Figure Southwest China Cancer Pain Production Volume Share by Type (2018-2023)

    • Table Southwest China Cancer Pain Sales Volume by Application (2018-2023)

    • Table Southwest China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Table Northwest China Cancer Pain Production Volume by Type (2018-2023)

    • Table Northwest China Cancer Pain Production Volume Share by Type (2018-2023)

    • Figure Northwest China Cancer Pain Production Volume Share by Type (2018-2023)

    • Table Northwest China Cancer Pain Sales Volume by Application (2018-2023)

    • Table Northwest China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Cancer Pain Sales Volume Share by Application (2018-2023)

    • Table Grunenthal Group Company Profile

    • Table Grunenthal Group Cancer Pain Revenue, Price and Gross (2018-2023)

    • Table BioDelivery Science Company Profile

    • Table BioDelivery Science Cancer Pain Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Cancer Pain Revenue, Price and Gross (2018-2023)

    • Table Johnson?Johnson Company Profile

    • Table Johnson?Johnson Cancer Pain Revenue, Price and Gross (2018-2023)

    • Table Teva pharmaceuticals Company Profile

    • Table Teva pharmaceuticals Cancer Pain Revenue, Price and Gross (2018-2023)

    • Table Orexo Company Profile

    • Table Orexo Cancer Pain Revenue, Price and Gross (2018-2023)

    • Table ProStrakan Group Company Profile

    • Table ProStrakan Group Cancer Pain Revenue, Price and Gross (2018-2023)

    • Table GW Pharmaceuticals Company Profile

    • Table GW Pharmaceuticals Cancer Pain Revenue, Price and Gross (2018-2023)

    • Table Eli-Lilly Company Profile

    • Table Eli-Lilly Cancer Pain Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US